ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol

June 14, 1991

Cancer Control Budget Still $4 Million Short

January 28, 1977

NTP Board Oks Seven Compounds For Tests

April 22, 1983

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000